|Day Low/High||42.43 / 43.09|
|52 Wk Low/High||32.78 / 51.86|
I attended the LD Micro Conference in Los Angeles. Here's what I found out.
A recent trio of acquisition deals indicates the doldrums in the sector may be over.
With earnings season starting in earnest Wednesday, both indexes have offered investors nothing but lower highs coupled with lower lows since the start of September.
Plus, a look at where central bank policies appear to be heading.
It was as if markets heard what they wanted to hear, when it was actually much more simple: markets heard exactly what they had anticipated.
The New York Fed's August Survey of Consumer Expectations could be problematic.
Plus, Zscaler largely delivers for its owners with its latest results.
What if areas of expected growth in labor market demand moving forward do not materialize?
The beaten-down biotech sector had one of the best weeks in a year. Are these names still oversold?
While all cyclical equity sectors did well, last week's push into more economically sensitive equities was indeed led by the energy sector.
Plus, a look at Dollar General and Peloton Interactive, which both disappointed with their announcements on Thursday.
What the charts are telling us right now about everyone's favorite stock, and everyone's favorite meme stock.
I could be wrong, but as far as I can tell, nobody else is telling the story about the sudden movement in these yields.
And It comes after one of the best days of the year for the biotech sector.
One cannot say that the financial marketplace is completely disrespecting or indifferent to what Fed Chair Powell may signal.
Incompetence, omissions and even outright lies have categorized this federal attempt to 'stem' the pandemic.
The fiscal football remains a greater threat this week than anything Fed Chair Jerome Powell says on Zoom this Friday.
This COVID-19 vaccine is the potential savior of more than just the market.
Many of the stocks favored by speculative traders are coming on strong.
Investors come into this week with 'all eyes' on the Kansas City Fed's economic symposium come week's end.
Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.
Plus, checking out trades related to Amazon, Macy's and a few defense and metals stocks.
We're seeing a group move in pharma right now, so let's sort it out, pill by pill.
We just got hit with a two-by-four, but in your daze, don't confuse this retailer's report with the entire market and economy.
The tables have turned, their stocks have been up, and I think they go higher still.
A wall of liquidity seems to absorb every dip. But there are also enough reasons to be ever vigilant.